{"id":"https://genegraph.clinicalgenome.org/r/e3858e1f-def8-44b8-aa46-de953ead3d41v1.0","type":"EvidenceStrengthAssertion","dc:description":"RPS6KB1 was first reported in relation to autosomal dominant hypertrophic cardiomyopathy in 2022 (Jain PK, et al.; PMID: 34916228). Three missense variants that have been reported in four cases in one publication are included in this curation (PMID: 34916228). The mechanism of pathogenicity is reported to be gain of function. This gene-disease relationship is also supported by expression data (PMID: 34916228, 32913098), a biochemical function assay demonstrating the involvement of RPS6KB1 in the increased phosphorylation of the ERK 1/2 pathway, functional alteration in HEK293T cells, and a mouse cardiomyocyte cell model that showed hypertrophy and upregulation of hypertrophic markers (PMID: 34916228).  In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Hereditary Cardiovascular Disease GCEP on the meeting date 09/13/2023 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/e3858e1f-def8-44b8-aa46-de953ead3d41","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2e24747c-18e6-4db0-8ee7-1259bc74c4da","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2e24747c-18e6-4db0-8ee7-1259bc74c4da_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2023-10-10T21:02:24.866Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/2e24747c-18e6-4db0-8ee7-1259bc74c4da_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10104","date":"2023-09-13T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e24747c-18e6-4db0-8ee7-1259bc74c4da_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e24747c-18e6-4db0-8ee7-1259bc74c4da_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d3068b42-a6cb-4fdb-9fbe-e57d19b89d0a","type":"EvidenceLine","dc:description":"These results suggest that the cardiac hypertrophy observed in WTS6K1 transgenics was due to overexpression of WTS6K1; S6Ks alone are not critical for the induction of cardiac hypertrophy.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4caea34d-bad4-412e-bb19-c8d3e303213a","type":"Finding","dc:description":"Since increased heart size was due to overexpression and not protein activity, the model phenotype is not similar to that observed in humans. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15226426","rdfs:label":"McMullen Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/500472c7-fe9b-4104-9a97-563e449c8755","type":"EvidenceLine","dc:description":"The experts would prefer the total for the cell model and the functional alteration entry to total 1 pt due to the methods and results of these studies not being very strong pieces of evidence. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/238d4590-a066-49ad-aca9-a1b3bee6c849","type":"Finding","dc:description":"Cells show hypertrophy, upregulation of hypertrophic markers, and increased protein expression. These results suggest that the S6K1 variant induces cardiac hypertrophy.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","rdfs:label":"Jain Cell Culture Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2e24747c-18e6-4db0-8ee7-1259bc74c4da_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f32d8c62-f363-4a1e-ad05-267a86b80214","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16d2f2b0-cc47-4103-b49e-d59cd4197278","type":"FunctionalAlteration","dc:description":"Variants activate S6K1/rpS6 and its associated pathways","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","rdfs:label":"Jain Functional Alteration"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2e24747c-18e6-4db0-8ee7-1259bc74c4da_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a65c886-4fc9-474a-8a49-38c9f822f8ad","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e555ebb0-df4e-42de-8afa-1eef33b90239","type":"Finding","dc:description":"Extracellular signal-regulated kinase (ERK) 1 and 2 serve an evolutionarily conserved role for intracellular signal transduction that proved critical for cardiomyocyte homeostasis and cardiac stress responses. Sustained ERK1/2 activation was reported in patients with pathological cardiac hypertrophy","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","rdfs:label":"Jain Biochemical Function","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0eb13276-6df1-4c7c-bbec-946a9570720e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b71300b-f248-483b-9ddb-242227f7c5d4","type":"Finding","dc:description":"Immunoblots with indicated proteins from the endomyocardial biopsy lysates from P1 and control subjects (C1 and C2) without cardiomyopathy, respectively. The lysates from the genotype-positive patient tissue sample showed enhanced S6K1 and rpS6 activity by hyperphosphorylating T389 and S240/244 sites compared with controls.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","rdfs:label":"Jain Expression B","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b633ae87-41db-4adb-8729-043177ac4735","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b4a7558b-d3c3-4a25-921b-500b7a10ab48","type":"Finding","dc:description":"GTEx expression is ubiquitous, but is present in the heart. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32913098","rdfs:label":"GTEx Expression ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/2e24747c-18e6-4db0-8ee7-1259bc74c4da_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c08ad28-6782-43ad-b6e0-14c731e9994e","type":"EvidenceLine","dc:description":"This proband has a missense variant, Gln49Lys, that is absent in gnomAD ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c08ad28-6782-43ad-b6e0-14c731e9994e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","allele":{"id":"https://genegraph.clinicalgenome.org/r/68d833ad-5aeb-46f9-8a46-52f92b96044d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003161.4(RPS6KB1):c.145C>A (p.Gln49Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400437067"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2e24747c-18e6-4db0-8ee7-1259bc74c4da_cc_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f58be6b0-168c-4934-9ff3-4374fce335c0","type":"EvidenceLine","dc:description":"The experts did not feel confident in the methods for this case-control study and would like the cases to be curated at the case level instead.  ","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f58be6b0-168c-4934-9ff3-4374fce335c0_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","rdfs:label":"Jain Cohorts 1&2","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/2abe696f-a64f-4cee-858d-7a8e2c1efcfd","type":"Cohort","allGenotypedSequenced":401,"alleleFrequency":0.007481296758104738,"detectionMethod":"WES, PCR (cohort 1); exons and their flanking intronic boundaries of S6K1 were amplified from genomic DNA. Amplified PCR products were purified with a QIAGEN PCR purification kit, sequenced and analysed (cohort 2)","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f58be6b0-168c-4934-9ff3-4374fce335c0_cc_evidence_item"}],"numWithVariant":3,"relatedCondition":{"id":"obo:MONDO_0005045"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/9221a3f6-1670-4dbc-909f-4a1c21f882d8","type":"Cohort","allGenotypedSequenced":3521,"alleleFrequency":0.0005680204487361545,"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f58be6b0-168c-4934-9ff3-4374fce335c0_cc_evidence_item"}],"numWithVariant":2},"lowerConfidenceLimit":2.2,"method":{"id":"cg:AggregateVariantAnalysis"},"pValue":0.001,"statisticalSignificanceType":"","statisticalSignificanceValue":13,"statisticalSignificanceValueType":"Odds Ratio","upperConfidenceLimit":79.6}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/2d2bd912-84c5-4864-9963-ab4e8937be0b","type":"EvidenceLine","dc:description":"The experts did not feel confident in the methods for this case-control study and would prefer the cases to be scored at the case level. ","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d2bd912-84c5-4864-9963-ab4e8937be0b_cc_evidence_item","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","rdfs:label":"Jain Cohort 3","caseCohort":{"id":"https://genegraph.clinicalgenome.org/r/c4716243-2d23-4a8b-bca9-473b2516c381","type":"Cohort","allGenotypedSequenced":190,"alleleFrequency":0.01052631578947368,"detectionMethod":"UK BioBank cardiomyopathy exomes","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d2bd912-84c5-4864-9963-ab4e8937be0b_cc_evidence_item"}],"numWithVariant":2,"relatedCondition":{"id":"obo:MONDO_0005045"}},"controlCohort":{"id":"https://genegraph.clinicalgenome.org/r/c6c898c1-159e-4473-a319-d81d731f4622","type":"Cohort","allGenotypedSequenced":16479,"alleleFrequency":0.0002427331755567692,"detectionMethod":"UK BioBank cardiomyopathy exomes","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d2bd912-84c5-4864-9963-ab4e8937be0b_cc_evidence_item"}],"numWithVariant":4},"lowerConfidenceLimit":7.9,"method":{"id":"cg:AggregateVariantAnalysis"},"pValue":0.00010,"statisticalSignificanceType":"","statisticalSignificanceValue":43.8,"statisticalSignificanceValueType":"Odds Ratio","upperConfidenceLimit":240}],"specifiedBy":"GeneValidityCaseControlAggregateVariantAnalysisCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallCaseControlEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/bddff198-1664-4787-8ca6-39b7889e0510","type":"EvidenceLine","dc:description":"MAF=0.004090 (41/10024 alleles) in the Ashkenazi Jewish population, but 0.0001063 (12/112914 alleles) in the European NF population. This proband receives a reduced score due to the MAF being too high","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bddff198-1664-4787-8ca6-39b7889e0510_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","allele":{"id":"https://genegraph.clinicalgenome.org/r/5ac7c284-cb89-476f-ad30-f29e1b96d44f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003161.4(RPS6KB1):c.1333C>T (p.Pro445Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8683027"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/1ffbf492-8b8b-4ed5-ae52-647d44f9c782","type":"EvidenceLine","dc:description":"This proband has a missense variant, Tyr62His, that is absent in gnomAD v2.1.1. ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ffbf492-8b8b-4ed5-ae52-647d44f9c782_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","allele":{"id":"https://genegraph.clinicalgenome.org/r/4a4fd2c3-f199-41d2-8659-b9517106247d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003161.4(RPS6KB1):c.184T>C (p.Tyr62His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400437249"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/87bad072-3305-49d3-976b-43c4ec275ad0","type":"EvidenceLine","dc:description":"This proband has a missense variant, Gly47Trp, that is absent from gnomAD v2.1.1 ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/87bad072-3305-49d3-976b-43c4ec275ad0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","allele":{"id":"https://genegraph.clinicalgenome.org/r/ed2248b1-1024-44b8-9df6-f65678a22584","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003161.4(RPS6KB1):c.139G>T (p.Gly47Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400435865"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c7c8a9d1-0e11-42fa-8119-7c5a86441ae7","type":"EvidenceLine","dc:description":"This proband has a missense variant, Gly47Trp, that is absent from gnomAD v2.1.1 ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7c8a9d1-0e11-42fa-8119-7c5a86441ae7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34916228","allele":{"id":"https://genegraph.clinicalgenome.org/r/ed2248b1-1024-44b8-9df6-f65678a22584"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0.4}],"evidenceStrength":"Limited","sequence":7059,"specifiedBy":"GeneValidityCriteria9","strengthScore":2.9,"subject":{"id":"https://genegraph.clinicalgenome.org/r/g6BseKA16LQ","type":"GeneValidityProposition","disease":"obo:MONDO_0005045","gene":"hgnc:10436","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2e24747c-18e6-4db0-8ee7-1259bc74c4da-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}